236 related articles for article (PubMed ID: 37159471)
1. Leveraging health infrastructure to optimize HPV vaccination for adolescents in Zambia: Protocol for an implementation study.
Miti S; Shato T; Asante C; Baumann A; Chongwe G; Bobo PM; Silver MI; Hunleth JM
PLoS One; 2023; 18(5):e0285031. PubMed ID: 37159471
[TBL] [Abstract][Full Text] [Related]
2. Human Papillomavirus Vaccination in South Africa: Programmatic Challenges and Opportunities for Integration With Other Adolescent Health Services?
Amponsah-Dacosta E; Blose N; Nkwinika VV; Chepkurui V
Front Public Health; 2022; 10():799984. PubMed ID: 35174123
[TBL] [Abstract][Full Text] [Related]
3. Health professional feedback on HPV vaccination roll-out in a developing country.
Venturas C; Umeh K
Vaccine; 2017 Apr; 35(15):1886-1891. PubMed ID: 28291647
[TBL] [Abstract][Full Text] [Related]
4. Challenges and lessons from a school-based human papillomavirus (HPV) vaccination program for adolescent girls in a rural Nigerian community.
Egbon M; Ojo T; Aliyu A; Bagudu ZS
BMC Public Health; 2022 Aug; 22(1):1611. PubMed ID: 36002832
[TBL] [Abstract][Full Text] [Related]
5. Optimal human papillomavirus vaccination strategies to prevent cervical cancer in low-income and middle-income countries in the context of limited resources: a mathematical modelling analysis.
Drolet M; Laprise JF; Martin D; Jit M; Bénard É; Gingras G; Boily MC; Alary M; Baussano I; Hutubessy R; Brisson M
Lancet Infect Dis; 2021 Nov; 21(11):1598-1610. PubMed ID: 34245682
[TBL] [Abstract][Full Text] [Related]
6. An evaluation of the cost of human papilloma virus (HPV) vaccine delivery in Zambia.
Simuyemba MC; Chama-Chiliba CM; Chompolola A; Sinyangwe A; Bchir A; Asiimwe G; Chibwesha C; Masiye F
BMC Infect Dis; 2024 Apr; 24(1):369. PubMed ID: 38565994
[TBL] [Abstract][Full Text] [Related]
7. National introduction of human papillomavirus (HPV) vaccine in Tanzania: Programmatic decision-making and implementation.
Mphuru A; Li AJ; Kyesi F; Mwengee W; Mazige F; Nshunju R; Shayo B; Giattas MR; Loharikar A; Lyimo D
Vaccine; 2022 Mar; 40 Suppl 1(Suppl 1):A2-A9. PubMed ID: 33962839
[TBL] [Abstract][Full Text] [Related]
8. Implementation of a provider-focused intervention for maximizing human papillomavirus (HPV) vaccine uptake in young cancer survivors receiving follow-up care in pediatric oncology practices: protocol for a cluster-randomized trial of the HPV PROTECT intervention.
Landier W; Bhatia S; Richman JS; Campos Gonzalez PD; Cherven B; Chollette V; Aye J; Castellino SM; Gramatges MM; Lindemulder S; Russell TB; Turcotte LM; Colditz GA; Gilkey MB; Klosky JL
BMC Pediatr; 2022 Sep; 22(1):541. PubMed ID: 36096775
[TBL] [Abstract][Full Text] [Related]
9. Impact of one and two human papillomavirus (HPV) vaccine doses on community-level HPV prevalence in South African adolescent girls: study protocol and rationale for a pragmatic before-after design.
Machalek D; Rees H; Chikandiwa A; Munthali R; Travill D; Mbulawa Z; Petoumenos K; Delany-Moretlwe S; Kaldor J;
BMJ Open; 2022 Feb; 12(2):e059968. PubMed ID: 35144959
[TBL] [Abstract][Full Text] [Related]
10. Using an Implementation Research Framework to Identify Potential Facilitators and Barriers of an Intervention to Increase HPV Vaccine Uptake.
Selove R; Foster M; Mack R; Sanderson M; Hull PC
J Public Health Manag Pract; 2017; 23(3):e1-e9. PubMed ID: 27902559
[TBL] [Abstract][Full Text] [Related]
11. Facilitators and barriers of human papillomavirus vaccine uptake in young females 18-26 years old in Singapore: A qualitative study.
Lim ASE; Lim RBT
Vaccine; 2019 Sep; 37(41):6030-6038. PubMed ID: 31473002
[TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness analysis of human papillomavirus vaccination in South Africa accounting for human immunodeficiency virus prevalence.
Li X; Stander MP; Van Kriekinge G; Demarteau N
BMC Infect Dis; 2015 Dec; 15():566. PubMed ID: 26652918
[TBL] [Abstract][Full Text] [Related]
13. Interventions to improve human papillomavirus vaccination among Chinese female college students: study protocol for a randomized controlled trial.
Si M; Su X; Jiang Y; Qiao Y; Liu Y
BMC Public Health; 2019 Nov; 19(1):1546. PubMed ID: 31752785
[TBL] [Abstract][Full Text] [Related]
14. The effectiveness of pay-it-forward in addressing HPV vaccine delay and increasing uptake among 15-18-year-old adolescent girls compared to user-paid vaccination: a study protocol for a two-arm randomized controlled trial in China.
Li Y; Qin C; Qiu S; He Y; Pang L; Xu X; Yim VW; Tang S; Du H; Gong W; Yang F; Tucker JD; Tang W; Wang Y; Lin L; Jit M; Song W; Li C; Smith J; Li J; Wu D
BMC Public Health; 2023 Jan; 23(1):48. PubMed ID: 36609267
[TBL] [Abstract][Full Text] [Related]
15. Implementation strategies to increase human papillomavirus vaccination uptake for adolescent girls in sub-Saharan Africa: A scoping review protocol.
Lubeya MK; Mwanahamuntu M; Chibwesha C; Mukosha M; Wamunyima MM; Kawonga M
PLoS One; 2022; 17(8):e0267617. PubMed ID: 36006961
[TBL] [Abstract][Full Text] [Related]
16. Adolescent Health Series: HPV infection and vaccination in sub-Saharan Africa: 10 years of research in Tanzanian female adolescents - narrative review.
Whitworth H; Changalucha J; Baisley K; Watson-Jones D
Trop Med Int Health; 2021 Nov; 26(11):1345-1355. PubMed ID: 34310816
[TBL] [Abstract][Full Text] [Related]
17. Prevalence and genotype-specific distribution of human papillomavirus in Burundi according to HIV status and urban or rural residence and its implications for control.
Ndizeye Z; Vanden Broeck D; Lebelo RL; Bogers J; Benoy I; Van Geertruyden JP
PLoS One; 2019; 14(6):e0209303. PubMed ID: 31237894
[TBL] [Abstract][Full Text] [Related]
18. Implementation of a human papillomavirus vaccination demonstration project in Malawi: successes and challenges.
Msyamboza KP; Mwagomba BM; Valle M; Chiumia H; Phiri T
BMC Public Health; 2017 Jun; 17(1):599. PubMed ID: 28651574
[TBL] [Abstract][Full Text] [Related]
19. HPV vaccination coverage in three districts in Zimbabwe following national introduction of 0,12 month schedule among 10 to 14 year old girls.
LaMontagne DS; Manangazira P; Marembo J; Chigodo C; Zvamashakwe C; Tshuma E; Marima E; Chindedza K; Ndlela E; Mooney J
Vaccine; 2022 Mar; 40 Suppl 1():A58-A66. PubMed ID: 34275674
[TBL] [Abstract][Full Text] [Related]
20. Implementing the free HPV vaccination for adolescent girls aged below 14 in Shenzhen, Guangdong Province of China: experience, challenges, and lessons.
Wu D; Liu P; Song D; Wang H; Chen S; Tang W; Zhao X; Zhao F; Wang Y
Infect Dis Poverty; 2023 Oct; 12(1):98. PubMed ID: 37899444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
